| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $200.97B | $164.50B | $134.90B | $116.61B | $117.93B |
| Cost of Revenue | $36.17B | $30.16B | $25.96B | $25.25B | $22.65B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $57.37B | $43.87B | $38.48B | $35.34B | $24.66B |
| SG&A | $12.15B | $9.74B | $11.41B | $11.82B | $9.83B |
| Operating Income | $83.28B | $69.38B | $46.75B | $28.94B | $46.75B |
| Interest Expense | $1.09B | $683.00M | $446.00M | $185.00M | $23.00M |
| Tax Expense | $25.47B | $8.30B | $8.33B | $5.62B | $7.91B |
| Net Income | $60.46B | $62.36B | $39.10B | $23.20B | $39.37B |
| EPS (basic) | 23.9800 | 24.6100 | 15.1900 | 8.6300 | 13.9900 |
| EPS (diluted) | 23.4900 | 23.8600 | 14.8700 | 8.5900 | 13.7700 |
| Shares (diluted) | $2.57B | $2.61B | $2.63B | $2.70B | $2.86B |